Edition:
United Kingdom

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

7.67USD
21 Aug 2018
Change (% chg)

$0.40 (+5.50%)
Prev Close
$7.27
Open
$7.24
Day's High
$7.83
Day's Low
$7.23
Volume
60,359
Avg. Vol
170,008
52-wk High
$29.02
52-wk Low
$6.56

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Richard Murray

59 2014 President, Chief Executive Officer, Director

Kimberlee Drapkin

50 2015 Chief Financial Officer, Treasurer

Hugh Cole

53 2017 Chief Business Officer and Head of Corporate Development

Elizabeth Trehu

57 2015 Chief Medical Officer

J. Duncan Higgons

63 2015 Independent Director